26.07.2016
- Drugmakers who supply Medicare, the US health insurance for the elderly, are raking in billions of dollars for “pricey medications” at taxpayer expense, a report by the news agency...
02.12.2015
- Express Scripts Holding, the biggest pharmacy benefits manager in the US, said it plans to list Imprimis Pharmaceuticals’ cheaper alternative to the toxoplasmosis treatment...
07.10.2015
- The pharmaceutical industry is entering a period of sustained growth. Prescription drug sales are set to advance at almost 5% a year until 2020, while worldwide prescription drug...
20.01.2015
- Europe, where about 15 million people are believed to be infected with hepatitis C, could become the next battleground between US drugmakers Gilead Sciences and AbbVie in their...
19.01.2015
- The largest US health insurer, Aetna, has negotiated a discount for Gilead Sciences' hepatitis C treatment regime and said it plans to offer this as a preferred choice for its...
23.12.2014
- The largest pharmacy benefit manager in the US, Express Scripts, has negotiated a cheaper price from AbbVie for its Viekira Pak hepatitis C treatment approved by the US Food and...
02.10.2014
- France plans to implement a tax on hepatitis C drugs in an effort to lower the high prices that the government of prime minister Francois Hollande believes threaten the country's...
10.06.2014
- Merck & Co has announced it will buy Idenix Pharmaceuticals for $3.85 billion. The US drugmaker plans to combine the most promising drugs in the two portfolios to produce a faster...
